Contemporary scientific research reflects a growing focus on complexity and collaboration. Novel therapeutic modalities - mRNA therapeutics, antibody–drug conjugates, and cell and gene therapies - now ...
Regulators found the company had relied heavily on AI systems to generate key documents, including drug specifications, procedures and production records, without sufficient human oversight.
The UK government has launched a landmark £500 million national effort, Sovereign AI, designed to transform Britain into a global leader in artificial intelligence by backing its most promising ...
This addition further expands Qlucore's portfolio of advanced testing solutions, which already includes Qlucore Insights Leukaemia (AML), Qlucore Insights Lung Cancer and Qlucore Diagnostics Pediatric ...
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with: ...
VAST Data, the AI Operating System company, today announced the closing of its Series F financing at a $30 billion valuation, representing more than a threefold increase from its $9.1 billion Series E ...
As the drug discovery community navigates the transition from manual, paper-based workflows to digitally enhanced environments, contract research organizations (CROs) like Novalix are leading the ...
The platform offers access to more than 40 AI biology models, supported by AI-guided selection tools that help researchers choose the most suitable models for their specific goals.
Credit: Jülich Supercomputing Centre The EuroHPC Federation Platform provides a unified single access point that transforms how European researchers, businesses and public sector organisations can acc ...
State of the Global Quantum Industry report reveals the "growth of European leadership and the speed that the industry is ...
Credit: R. Jacobson/NIST NIST’s chips could help emerging technologies such as quantum computers and optical atomic clocks escape the lab and start to impact biomedicine, navigation, communications ...